Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor
about
Principles of interleukin (IL)-6-type cytokine signalling and its regulationgp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathwaysStimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinaseDifferential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathwaysCytokine signaling in the brain: putting a SOCS in it?Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterolTranscriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cellsCNTF-evoked activation of JAK and ERK mediates the functional expression of T-type Ca2+ channels in chicken nodose neurons.Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinomaThe central role of SOCS-3 in integrating the neuro-immunoendocrine interfaceZap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling.Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantationHeme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling.Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes.The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.Biology and significance of the JAK/STAT signalling pathways.Discovery and replication of a peripheral tissue DNA methylation biosignature to augment a suicide prediction model.SHP-1 arrests mouse early embryo development through downregulation of Nanog by dephosphorylation of STAT3The human POMC gene promoter: where do we stand?STAT3 Target Genes Relevant to Human Cancers.Phosphorylation states of STAT3 and ERKs in mouse embryonic stem cells.Requirement of histone deacetylase activity for signaling by STAT1.Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.Identification of a novel gp130-responsive site in the vasoactive intestinal peptide cytokine response element.E2F1-mediated human POMC expression in ectopic Cushing's syndrome.Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.Control mechanism of JAK/STAT signal transduction pathway.Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
P2860
Q24530173-C37C3684-590D-4555-B2CF-8FC533687649Q24670572-46B75F28-AEB0-4460-95C7-EBE8ADDEB74EQ28138574-6EB41940-71B0-479B-BFAE-A343430A687CQ28143778-12B3DC71-B281-41D5-9ACC-0D6621970BD0Q28218029-FB36E653-B35C-4833-A3BA-40A8805F0E79Q28476834-03023F86-BCE8-45C6-957E-A80733125B11Q30176405-96B62CDD-E22A-4CE8-ABD4-CCE287FAC7CFQ34156262-15A67AA2-917C-45ED-8EC5-BE74D0911AB4Q34333812-22E2C05E-A2E3-4FE5-8129-C09279B07D29Q34347235-F746CAF8-7AE7-4CE3-AAF4-398234A4EDCDQ34465560-8D6BA2B5-6908-4AB2-B860-B69B273D5A12Q35188994-15426A55-D0B6-4F03-A09F-6239619A0B36Q35777741-E18C9E9F-3AE2-4EEF-BA1E-7B18CB45513EQ36012548-E89E69F6-78C8-4E7E-8005-1D9E7C985BC7Q36369420-3890215A-3823-43BA-8804-AB264E0106ECQ36595887-D7C48546-05DE-4163-BECC-8B2F4D6C685DQ36825535-30AD6004-16B8-4748-ABCB-52AB4007A18FQ36836455-176EA0C8-5039-4804-BB4F-3F0ED00B7FFFQ37146441-191FE0DB-FFD1-4943-AD49-8F202D7EA995Q37390809-917E6225-3982-4EC6-B69E-4DE1EFE40A06Q37500252-0B4C59A2-464D-4479-BF39-5467E6AB1C01Q37861470-D95A585F-9B58-42F6-B0BA-91F04BB09A67Q38205362-54B3D60F-3079-4964-BB85-D83A1093A78BQ39742952-42796EC1-6341-434D-B366-50CF78B304D4Q40559904-4D959040-C638-427D-A599-84A282DE6ABCQ40736055-89BCB00B-0CF8-4C8B-A2C6-D2CD86518983Q40858034-9D3DD7AA-6FE2-4EDF-92EB-76C88E3917AAQ42856188-A0DF7E7D-6A2C-4062-BE86-301A799D28E1Q43948702-0EB22943-7F34-4F5C-8B5D-83A661F3A4B1Q44236067-106EB35E-6B98-4A66-BF6E-DB830D860404Q44277958-2BEF046B-33D6-4CC1-8094-EA8CE8D3CB5FQ54508147-4E537A64-0165-4F62-8F56-7F8093B3F64E
P2860
Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@ast
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@en
type
label
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@ast
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@en
prefLabel
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@ast
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@en
P2093
P2860
P356
P1476
Inhibitory roles for SHP-1 and ...... by leukemia inhibitory factor
@en
P2093
P2860
P304
P356
10.1172/JCI7924
P407
P577
1999-11-01T00:00:00Z